The Future of Engineered Tissue
Frontier Bio has raised $1.3M in total funding. The most recent round was Seed. The last funding was announced in December 2024.
Frontier Bio's investors include National Science Foundation, Alchemist Accelerator, SkyDeck Berkeley, Brinc, Artesian VC.
Frontier Bio is headquartered in Hayward, United States.
The Future of Engineered Tissue
Frontier Bio is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Frontier Bio — Funding & Investors." VCBacked, December 25, 2024, https://www.vcbacked.co/company/frontier-bio. Accessed October 31, 2026.
VCBacked. (2024). Frontier Bio — Funding & Investors. Retrieved October 31, 2026, from https://www.vcbacked.co/company/frontier-bio
{{cite web |title=Frontier Bio — Funding & Investors |url=https://www.vcbacked.co/company/frontier-bio |website=VCBacked |access-date=October 31, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated